Growth Capital For Life Sciences & Healthcare
Telegraph Hill Partners is a venture capital firm dedicated to helping life science, medical device and healthcare companies achieve their growth objectives. When you work with us, you get an experienced team that knows how to drive growth and profitability while maintaining the vision and integrity of the organization.
We seek to partner with innovative companies by providing capital and strategic guidance to help them grow.
Latest News & Announcements
Magstim Acquires Electrical Geodesics, Inc. (EGI) Product Portfolio
High-density EEG complements Magstim’s Transcranial Magnetic Stimulation Technology Driving Innovation MINNEAPOLIS, Minn. & Carmarthenshire, UK — (July 2, 2020) – Magstim, the global leader in Transcranial Magnetic Stimulation (TMS), today announced an agreement to acquire the product portfolio [...]
Sirnaomics and Precision NanoSystems Have Formed a Partnership Developing and Manufacturing Novel RNAi Drug Candidates Using Precision NanoSystems’ NxGen™ Platform
Gaithersburg, MD, and Vancouver, Canada – Sirnaomics Inc. (Sirnaomics) and Precision NanoSystems Inc. (PNI) jointly announced a partnership on the development and manufacture of the polypeptide nanoparticle-based RNAi therapeutic product. This strategic joint effort includes the execution of a NanoA [...]
Agena Bioscience Announces EUA for High-Throughput, Low-Cost SARS-CoV-2 Panel
Agena Bioscience, a global provider of low cost and high-throughput molecular testing solutions, today announced the launch of the iPLEX® Pro SARS-CoV-2 Panel for qualitative detection of the novel coronavirus that causes COVID-19. Clinical laboratories can process more than 6000 samples each day ru [...]